The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The U.S. Centers for Disease Control and Prevention (CDC) has accepted recommendations from an advisory panel that endorsed ...

June 26 (UPI) -- Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

Pebsworth said she worried about coadministration of the shot with other childhood vaccines, despite data presented by the CDC's Vaccine Safety Datalink showing that RSV antibody shots being given ...

New CDC vaccine advisers vote to recommend Merck RSV antibody protection for babies Updated: 7:41 AM PDT Jun 26, 2025 Editorial Standards ⓘ By Meg Tirrell, CNN ...

New CDC vaccine advisers vote to recommend Merck RSV antibody protection for babies Updated: 10:41 AM EDT Jun 26, 2025 Editorial Standards ⓘ By Meg Tirrell, CNN ...